New universal flu vaccine trial begins: could it stop the next pandemic?

NCT ID NCT07215858

First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 29 times

Summary

This study tests an experimental flu vaccine called BPL-1357 in 129 healthy adults aged 18 to 55. The vaccine is given as a shot or nasal spray, and participants are later exposed to the flu virus in a controlled hospital setting to see if the vaccine prevents illness. The goal is to find a vaccine that works against many flu types, including potential pandemic strains.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INFLUENZA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • National Institutes of Health Clinical Center

    RECRUITING

    Bethesda, Maryland, 20892, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • University of Texas Medical Branch, Galveston

    NOT_YET_RECRUITING

    Galveston, Texas, 77555, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.